Hologic Inc

US

HOLX

Health Care

76.22 ₽

Current price

Sell
76.22 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    417 / 663

  • Position in country

    10006 / 14179

  • Return on Assets, %

    5.6

    -11.9

  • Net income margin, %

    24.3

    -12.5

  • EBITDA margin, %

    31.1

    -2.5

  • Debt to Equity, %

    55.3

    15

  • Intangible assets and goodwill, %

    48.8

    3.9

  • Revenue CAGR 3Y, %

    2.1

    12.6

  • Total Equity change 1Y, %

    -8.7

    0

  • Revenue Y, % chg

    -11.2

    4.6

  • P/E

    36.7

    28.3

  • P/BV

    3.8

    1.7

  • P/S

    4.5

    3.7

  • EV/S

    4.7

    3.2

  • EV/EBITDA

    15.2

    -0.2

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    9.9

    66.5

  • Forward P/E

    18.3

    19.2

  • Expected dividend per share

    0

    0

  • Payout Ratio, %

    0

    17.3

Get an analytical review of this company

Competitors

Ranks

  • Dexcom Inc

    00%

  • Boston Scientific Corp

    00%

  • Intuitive Surgical Inc

    00%

  • Stryker Corp

    00%

  • Edwards Lifesciences Corp

    00%

  • IDEXX Laboratories Inc

    00%

  • Abbott Laboratories

    00%

  • GE Healthcare Technologies Inc

    00%

  • Hologic Inc

    00%

  • Becton Dickinson and Co

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    18151.7

  • Ticker

    HOLX.O

  • ISIN

    US4364401012

  • IPO date

    1990-03-01

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-02

  • Date fact. publication of reports

    2023-12-30

Company Description

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a range of diagnostics products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a portfolio of solutions for breast cancer care for radiology, pathology and surgery. The GYN Surgical segment offers a range of products, including its NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System as well as its Fluent Fluid Management system. The Skeletal Health segment offers products such as the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm.